Upstream Bio Presents Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma in Oral Presentation at ERS Congress 2026Globe Newswire•08/09/2026•07:300 ShareWhiz InsightsGenerateNo content available.
